|

KarXT + KarX-EC Arm Matching Placebo Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Bristol-Myers Squibb1

Indications

  • Alzheimer's Disease1
  • Psychosis1
  • Alzheimer Disease1

Gilbert, Arizona1 trial

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

Local Institution - 0042

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.